Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2021
DOI: 10.1016/j.aca.2021.338848
|View full text |Cite
|
Sign up to set email alerts
|

Advancing sensing technology with CRISPR: From the detection of nucleic acids to a broad range of analytes – A review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
21
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 48 publications
(21 citation statements)
references
References 128 publications
0
21
0
Order By: Relevance
“…Cas12 is divided into three subtypes: Cas12a (Cpf1), Cas12b (C2c1), and Cas12c (C2c3) (Shmakov et al., 2015). Of these, Cas12a is the most common (Xie et al., 2021). It is a single RNA‐required effector protein, and does not require tracrRNA.…”
Section: Classification Of Crispr/cas Systemsmentioning
confidence: 99%
See 1 more Smart Citation
“…Cas12 is divided into three subtypes: Cas12a (Cpf1), Cas12b (C2c1), and Cas12c (C2c3) (Shmakov et al., 2015). Of these, Cas12a is the most common (Xie et al., 2021). It is a single RNA‐required effector protein, and does not require tracrRNA.…”
Section: Classification Of Crispr/cas Systemsmentioning
confidence: 99%
“…CRISPR biosensing has been applied in diverse fields including biosecurity, food safety, life science, environmental monitoring, and medical diagnostics; and despite being in its early stages of development, it is widely expected to take food‐safety monitoring to the next level (Xie et al., 2021). For the food industry, in particular, the potential of this novel biosensing method is enormous, because in addition to bacterial pathogens it can be used to detect viruses, genetically modified organisms (GMOs), toxins, and food additives (Abnous et al., 2021; D. Huang et al., 2020; Jiao et al., 2021; Qiao et al., 2021).…”
Section: Introductionmentioning
confidence: 99%
“…In future development, these issues can be addressed by exploiting the most recent advances in the technologies related to the different components of the sensors and biosensors. For example, the latest results in biotechnology are opening to the possibility of designing highly selective biosensors by tuning the affinity of the biological receptors to selected VOCs thanks to gene editing techniques [ 203 , 204 ]. Additionally, progress in microfabrication can lead to a substantial decrease in production costs, to large scale fabrication of nominally identical structures, and to the possibility of integrating different sensors and biosensors [ 205 ].…”
Section: Conclusion: Challenges and Opportunitiesmentioning
confidence: 99%
“…CRISPR/Cas system, which normally plays the role of a bacterial immune systems [ 14 , 15 ], has been developed into powerful tools for genome editing [ 16 , 17 ], genome imaging [ 18 ], cell imaging [ [19] , [20] , [21] ], and disease treatment [ [22] , [23] , [24] ]. The CRISPR/Cas system is also a promising platform for next-generation molecular detection technologies with high sensitivity and specificity that require no special instrumentation [ 25 , 26 ]. The trans-cleavage activity of Cas effector proteins (such as Cas12, Cas13, Cas14, etc.)…”
Section: Introductionmentioning
confidence: 99%